Inmune Bio Files 8-K Report
Ticker: INMB · Form: 8-K · Filed: Jul 25, 2025 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | 8-K |
| Filed Date | Jul 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, reporting
Related Tickers: INMB
TL;DR
INMB filed an 8-K, mostly routine stuff, no major news.
AI Summary
On July 24, 2025, Inmune Bio, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no specific material events detailed in the provided text. The company is incorporated in Nevada and its principal executive offices are located in Boca Raton, Florida.
Why It Matters
This filing indicates routine corporate reporting activity for Inmune Bio, Inc., which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — The filing appears to be a routine 8-K with no immediately disclosed material events or significant financial changes.
Key Players & Entities
- Inmune Bio, Inc. (company) — Registrant
- July 24, 2025 (date) — Date of earliest event reported
- Boca Raton, Florida (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Inmune Bio, Inc.?
The filing is primarily for "Other Events" and "Financial Statements and Exhibits" as of July 24, 2025.
When was the earliest event reported in this filing?
The earliest event reported was on July 24, 2025.
Where are Inmune Bio, Inc.'s principal executive offices located?
The principal executive offices are located at 225 NE Mizner Blvd., Suite 640, Boca Raton, Florida 33432.
What is the state of incorporation for Inmune Bio, Inc.?
Inmune Bio, Inc. is incorporated in Nevada.
What is the company's telephone number?
The registrant's telephone number is (858) 964-3720.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 25, 2025 regarding Inmune Bio, Inc. (INMB).